INM logo

INMInMed Pharmaceuticals Inc

$1.51
$0.07
(4.43%)
Today
Closed $1.51
$0.00
(0.00%)
After Hours
Updated: 04:10 PM EDT
Reported EarningsMay 13
Mkt Cap$5.24M
Vol39,521.00
44

Bearish Sentiment

How do you feel about INM?

News
all
press releases
Are GBTG, INM, CZR, TMHC Obtaining Fair Deals for their Shareholders?
Are GBTG, INM, CZR, TMHC Obtaining Fair Deals for their Shareholders? Are GBTG, INM, CZR, TMHC Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 12, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...
PR Newswire
News Placeholder
More News
News Placeholder
Are RAMP, INM, D, NEE Obtaining Fair Deals for their Shareholders?
Are RAMP, INM, D, NEE Obtaining Fair Deals for their Shareholders? Are RAMP, INM, D, NEE Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, May 28, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...
PR Newswire
News Placeholder
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--RAMP, NEE, D, and INM
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--RAMP, NEE, D, and INM SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--RAMP, NEE, D, and INM PR Newswire NEW YORK, May 28, 2026 NEW YORK, May 28, 2026 /PRNewswire/ -- Class Action...
PR Newswire
News Placeholder
These Stocks are Riding Some of the Hottest Narratives on Wall Street
Here are today’s most compelling market narratives. $NTHI, $AMST, $MTVA, $AGYS, $INM, $CODX
24-7 Market News
News Placeholder
INM Stock Alert: Halper Sadeh LLC is Investigating Whether InMed Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the merger of InMed Pharmaceuticals, Inc. (NASDAQ: INM) and Mentari Therapeutics, Inc. Upon closing of the proposed transaction, InMed...
Business Wire
News Placeholder
Penny Stock InMed Pharmaceuticals Merger Deal Targets Migraine Pipeline
InMed agrees to merge with Mentari Therapeutics to advance migraine drug candidates backed by $290 million in financing.read more...
Benzinga
News Placeholder
InMed Pharmaceuticals, Mentari Therapeutics To Merge
(RTTNews) - InMed Pharmaceuticals (INM) has entered into a definitive merger agreement for an all-stock transaction with Mentari Therapeutics, a privately-held biotechnology company developing therapies for migraine prevention, Indigo Merger Sub Corp. a subsidiary of InMed, and I...
Nasdaq News: Markets
News Placeholder
InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention Therapies
InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention Therapies InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention...
PR Newswire
News Placeholder
Nano-Cap InMed Ignites Retail Frenzy As Stock Soars After Alzheimer's Drug Trial Shows Promise
The positive trial results propelled InMed into the top 25 trending stocks on Stocktwits, with a flood of bullish comments on the platform.
Stocktwits
<
...
1
>

Advertisement|Remove ads.